Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemiaYajnavalka Banerjee, Manfredi Rizzo, Ali A. Rizvi et al.|Expert Opinion on Drug Safety|2021Cited by 53